These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8805320)

  • 1. Knockout mice and dirty drugs. Drug addiction.
    Uhl GR; Vandenbergh DJ; Miner LL
    Curr Biol; 1996 Aug; 6(8):935-6. PubMed ID: 8805320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter.
    Giros B; Jaber M; Jones SR; Wightman RM; Caron MG
    Nature; 1996 Feb; 379(6566):606-12. PubMed ID: 8628395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene.
    Carboni E; Spielewoy C; Vacca C; Nosten-Bertrand M; Giros B; Di Chiara G
    J Neurosci; 2001 May; 21(9):RC141: 1-4. PubMed ID: 11312315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter.
    Pifl C; Drobny H; Reither H; Hornykiewicz O; Singer EA
    Mol Pharmacol; 1995 Feb; 47(2):368-73. PubMed ID: 7870046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine.
    Kahlig KM; Galli A
    Eur J Pharmacol; 2003 Oct; 479(1-3):153-8. PubMed ID: 14612146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dopamine transporter: a crucial component regulating dopamine transmission.
    Jaber M; Jones S; Giros B; Caron MG
    Mov Disord; 1997 Sep; 12(5):629-33. PubMed ID: 9380041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New clues to brain dopamine control, cocaine addiction.
    Balter M
    Science; 1996 Feb; 271(5251):909. PubMed ID: 8584927
    [No Abstract]   [Full Text] [Related]  

  • 8. Cocaine and amphetamine elicit differential effects in rats with a unilateral injection of dopamine transporter antisense oligodeoxynucleotides.
    Silvia CP; Jaber M; King GR; Ellinwood EH; Caron MG
    Neuroscience; 1997 Feb; 76(3):737-47. PubMed ID: 9135047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism.
    Saunders C; Ferrer JV; Shi L; Chen J; Merrill G; Lamb ME; Leeb-Lundberg LM; Carvelli L; Javitch JA; Galli A
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6850-5. PubMed ID: 10823899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocaine, reward, movement and monoamine transporters.
    Uhl GR; Hall FS; Sora I
    Mol Psychiatry; 2002; 7(1):21-6. PubMed ID: 11803442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice.
    Sora I; Wichems C; Takahashi N; Li XF; Zeng Z; Revay R; Lesch KP; Murphy DL; Uhl GR
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7699-704. PubMed ID: 9636213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dopamine hypothesis of the reinforcing properties of cocaine.
    Kuhar MJ; Ritz MC; Boja JW
    Trends Neurosci; 1991 Jul; 14(7):299-302. PubMed ID: 1719677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of kappa-opioid receptor agonists on long-term cocaine use and dopamine neurotransmission.
    Collins SL; D'Addario C; Izenwasser S
    Eur J Pharmacol; 2001 Aug; 426(1-2):25-34. PubMed ID: 11525767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference.
    Sora I; Hall FS; Andrews AM; Itokawa M; Li XF; Wei HB; Wichems C; Lesch KP; Murphy DL; Uhl GR
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5300-5. PubMed ID: 11320258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal cocaine exposure: increased striatal dopamine transporter binding in offspring at 3 and 6 months of age.
    Koff JM; Miller LG
    Brain Res Bull; 1994; 33(2):223-4. PubMed ID: 8275343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions.
    Hall FS; Li XF; Sora I; Xu F; Caron M; Lesch KP; Murphy DL; Uhl GR
    Neuroscience; 2002; 115(1):153-61. PubMed ID: 12401330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dopamine control of neuroendocrine functions. New findings based on the study of transgenic animals].
    Jaber M
    Ann Endocrinol (Paris); 1997; 58(6):427-35. PubMed ID: 9686001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and expression of a cocaine-sensitive rat dopamine transporter.
    Kilty JE; Lorang D; Amara SG
    Science; 1991 Oct; 254(5031):578-9. PubMed ID: 1948035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual and combined effects of ethanol and cocaine on the human dopamine transporter in neuronal cell lines.
    Ho M; Segre M
    Neurosci Lett; 2001 Feb; 299(3):229-33. PubMed ID: 11165777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroadaptations involved in amphetamine and cocaine addiction.
    White FJ; Kalivas PW
    Drug Alcohol Depend; 1998; 51(1-2):141-53. PubMed ID: 9716936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.